Extens, Clearsight, a Swiss private investment company, and Coptis, a leading publisher of software for cosmetic laboratories, are joining forces to accelerate the company’s growth.
Established in 1999 by Anne Karagoz, Coptis develops specialised software to support cosmetic laboratories and raw material manufacturers in the formulation and regulatory compliance stages. Coptis' solutions enable the cosmetics industry to efficiently manage development projects, reduce time to market, and improve the quality and accuracy of the data. In addition to this software suite, Coptis offers high value-added services that enhance its customers' performance through a global regulatory database, a database of toxicological information on more than 3,000 substances, and a document database on more than 15,000 cosmetic raw materials.
For the first time, Coptis is opening up its capital to Extens, marking the second investment of its third fund currently being raised, and Clearsight, in order to accelerate its commercial and technical development strategy. Coptis enjoyed great success with the North American and Asian markets, stemming from the 2008 opening of a subsidiary in New York, and then in Singapore in 2016. The company aims to accelerate its deployment in these very dynamic markets and consolidate its position as a leader in Europe. This capital increase will also enable the company to develop its range of products by integrating new components into the existing software suite.